Early Detection Of Alzheimers Disease
Additionally, the SOBA test detected oligomers in 11 people from the studys control group. Upon studying the follow-up examination records, researchers found 10 of those people received diagnoses later in the life of either MCI or brain pathology consistent with Alzheimers disease.
Based on the science, given what is known in the field about the order of events in the molecular biochemistry/pathology, we expect the amyloid beta toxic oligomers to be one of the earliest triggers of the disease, prior to fibril and plaque formation and tau hyperphosphorylation , for example, Dr. Daggett said.
were hoping that our assay would detect toxic oligomers in presymptomatic individuals, but nonetheless we were surprised and pleased when it worked, she added.
How quickly might the SOBA laboratory test be available for doctors and patients to use?
Dr. Daggett reported the SOBA-AD version of the assay had been granted Breakthrough Device Status from the FDA, and AltPrep is pursuing commercialization. However, they do not yet have a firm timeline.
At AltPep we are working on our Alzheimers disease therapeutic, which is designed to bind the toxic oligomers, neutralize them, and stimulate their clearance, she added. In addition, we plan to pursue Breakthrough Status for our Parkinsons disease/Lewy body dementia test in plasma.
When Will An Mri Be Done To See If I Have Dementia
An MRI can be done as part of your healthcare providers testing and evaluations to determine if you are living with dementia.
Your healthcare provider will begin with a history of your symptoms. It is a good idea for a close friend or family member to go with you. Your healthcare provider will review your medical history and ask questions as to when your dementia symptoms began. At this point, they will check to ensure that no other preexisting conditions are causing your symptoms.
After your healthcare provider reviews your history, they will perform a physical exam and assess your overall health.
How Is Alzheimer’s Disease Diagnosed And Evaluated
No single test can determine whether a person has Alzheimer’s disease. A diagnosis is made by determining the presence of certain symptoms and ruling out other causes of dementia. This involves a careful medical evaluation, including a thorough medical history, mental status testing, a physical and neurological exam, blood tests and brain imaging exams, including:
Don’t Miss: How To Care For Someone With Frontotemporal Dementia
Elevated Levels Detected Long Before Symptoms Appeared
The disease is a consequence of high levels of amyloid and tau proteins in the brain.
The researchers took blood samples from 1,100 Swedish inhabitants over a number of years. They used their test to measure the presence of phosphorylated tau protein .
They then compared these blood tests with individuals who were subsequently diagnosed with Alzheimer’s.
The test revealed a strong link between elevated levels of this specific tau protein in the blood and the loss of nerve cells and impaired cognitive ability in Alzheimer’s disease several years later.
Blood Test Detects Alzheimers Early
Until recently, Alzheimers was diagnosed only after symptoms. A simple blood test could change that.
-
Currently, it is difficult to diagnose Alzheimers without symptoms.
-
This delays early treatments for the disease and medical and lifestyle preparations.
-
New blood tests could be possible following new research.
The seeds of Alzheimers are planted years, even decades before symptoms arise and the disease is diagnosed. At that point, the best treatment options slow the further progression of symptoms.
Those seeds are amyloid beta proteins that misfold and clump together, forming small aggregates called oligomers. Over time, through a process scientists are still trying to understand, those toxic oligomers of amyloid beta are thought to develop into Alzheimers.
What clinicians and researchers have wanted is a reliable diagnostic test for Alzheimers disease one that can detect signs of the disease before symptoms, such as cognitive impairment, happens.
University of Washington researchers have taken a big step towards that, having developed a laboratory test that can measure levels of amyloid beta oligomers in blood samples.
Finding patients earlier in the course of their disease will give them time to prepare and make changes that could help them later, explained senior study author Valerie Daggett, a professor of bioengineering at the University of Washington.
You May Like: Omega 3 Fish Oil And Alzheimer’s Disease
Brain Imaging For Dementia
Brain imaging plays an instrumental role in helping to rule out other treatable conditions that may be causing dementia-like symptoms. These include strokes, tumors, and other problems that can cause dementia.
What Brain Imaging Tests Will Be Ordered by Your Healthcare Provider?
Your doctor may order one of the following brain imaging tests.
1. MRI to Detect Dementia
An MRI uses a powerful magnetic field and radio frequency pulses to create a detailed picture of the brain to detect brain abnormalities and diagnose different conditions in the brain. An MRI may be able to detect whether a stroke has occurred.
2. Brain Functional Magnetic Resonance Imaging
In brain functional magnetic reasoning imaging, it uses magnetic resonance to measure blood flow and oxygen changes that take place in the active parts of the brain. This test helps assess the brain function that has been affected by a stroke, trauma, or different disease like Alzheimers Disease.
3. CT Scan
A CT scan combines an x-ray machine and highly powerful computers to create multiple images of the inside of the brain. A CT scan can detect degeneration of cells that is related to dementia and provide clues on the damage that may have occurred because of head injuries, stroke, or other brain diseases.
4. PET
5. Lumbar Puncture
Seeing your healthcare provider early can make a huge difference in your symptoms as well as your future treatment.
Why Early Detection And Diagnosis
- It can be a relief to understand what is going on, for the individual with Alzheimer’s and the family, and can provide time to plan for future care.
- It may allow preventive steps for brain health that could potentially delay some symptoms.
- Individuals with a cognitive impairment due to a treatable condition can receive appropriate treatments.
- Upon diagnosis, those with the disease can discuss treatments to slow progression with their medical professional. Scientists now believe that the damage to the brain that results from Alzheimers disease may begin much earlier than previously thoughtas much as a decade or more before symptoms appear. And it is likely that treatment will be most effective at the earlier, pre-symptomatic stage.
- Those who are diagnosed will receive more rapid access to innovative treatments that may soon enter the market. They can also join a clinical trial registry or participate in aclinical trial.
Early detection and diagnosis is a major focus for UsAgainstAlzheimers. We are working with internationally renowned experts to outline a national strategy for early diagnosis of Alzheimers and dementia. Our networks each work with partners on outreach to their communities and to health professionals to urge wider use of cognitive assessments and greater awareness of the benefits of early detection and diagnosis.
Read Also: Alzheimer’s Life Expectancy Calculator
What Happens If A Doctor Thinks It’s Alzheimer’s Disease
If a primary care doctor suspects Alzheimers, he or she may refer the patient to a specialist who can provide a detailed diagnosis or further assessment. Specialists include:
- Geriatricians, who manage health care in older adults and know how the body changes as it ages and whether symptoms indicate a serious problem.
- Geriatric psychiatrists, who specialize in the mental and emotional problems of older adults and can assess memory and thinking problems.
- Neurologists, who specialize in abnormalities of the brain and central nervous system and can conduct and review brain scans.
- Neuropsychologists, who can conduct tests of memory and thinking.
Memory clinics and centers, including Alzheimers Disease Research Centers, offer teams of specialists who work together to diagnose the problem. In addition, these specialty clinics or centers often have access to the equipment needed for brain scans and other advanced diagnostic tests.
Signs You May Need A Head Ct Scan
Some people with a family history of Alzheimers disease or dementia get a scan proactively for peace of mind. Others may have the scan after showing these symptoms of Alzheimers disease:
- Behavioral changes
- Difficulty understanding others when they speak
- Loss of appetite
- Mood changes, including irritability and depression
- Problems with depth perception
Memory loss is not inevitable with aging. If your loved one has memory loss and any of the above symptoms, it may be time to speak with your doctor about further testing.
Recommended Reading: Do Antidepressants Lead To Dementia
How Are Mris Used In The Diagnosis Of Alzheimers Disease
The 3D imaging that MRIs for Alzheimers provide makes it easy for physicians to spot abnormalities in the brain. These abnormalities can be potential markers of Alzheimers, but they could also be symptoms of other cognitive conditions some of which may even be reversible if caught in time.
One of the first areas of the brain to be affected by Alzheimers disease is the hippocampus, which is responsible for developing new memories and helps your brain store them. When the hippocampus shrinks as a result of Alzheimers, the brains ability to form and recall memories diminishes. An Alzheimers MRI produces 3D imaging of the hippocampus, clearly showing how many cells are present and how big it is.
The parietal lobe is another part of the brain that is negatively affected by Alzheimers. Its responsible for a lot of things, such as sensing the bodys location, doing calculations and visual perception. When the parietal lobe shrinks, it reduces our ability to do any of those things. The parietal lobes size can also indicate to doctors whether the patient is experiencing an onset of Alzheimers or another cognitive condition.
Acting Out Dreams Predicts Parkinsons And Other Brain Diseases
Enacted dreams could be an early sign of Parkinsons disease
Deena So’Oteh
Alan Alda was running for his life. The actor, best known for his role on the television series M*A*S*H, wasnt on a set. This threat was realor at least it felt that way. So when he saw a bag of potatoes in front of him, he grabbed it and threw it at his attacker. Suddenly, the scene shifted. He was in his bedroom, having lurched out of sleep, and the sack of potatoes was a pillow hed just chucked at his wife.
Acting out dreams marks a disorder that occurs during the rapid eye movement phase of sleep. Called RBD, for REM sleep behavior disorder, it affects an estimated 0.5 to 1.25 percent of the general population and is more commonly reported in older adults, particularly men. Apart from being hazardous to dreamers and their partners, RBD may foreshadow neurodegenerative disease, primarily synucleinopathiesconditions in which the protein -synuclein forms toxic clumps in the brain.
Not all nocturnal behaviors are RBD. Sleepwalking and sleep talking, which occur more often during childhood and adolescence, take place during non-REM sleep. This difference is clearly distinguishable in a sleep laboratory, where clinicians can monitor stages of sleep to see when a person moves. Nor is RBD always associated with a synucleinopathy: it can also be triggered by certain drugs such as antidepressants or caused by other underlying conditions such as narcolepsy or a brain stem tumor.
Also Check: How Many Alzheimer’s Patients In The Us
Professor Catches Student Cheating With Chatgpt: I Feel Abject Terror
The evolving and adapting nature of ChatGPT, a k a GPT3, could make the program a useful tool in scouting warning signs moving forward, according to lead study author Felix Agbavor.
GPT3s systemic approach to language analysis and production makes it a promising candidate for identifying the subtle speech characteristics that may predict the onset of dementia, Agbavor said. Training GPT-3 with a massive dataset of interviews some of which are with Alzheimers patients would provide it with the information it needs to extract speech patterns that could then be applied to identify markers in future patients.
Working in tandem with the National Institutes of Health, researchers had trained the AI with transcripts from a dataset in addition to speech recordings to test its ability to spot warnings of dementia. GPT was then retrained to become an Alzheimers detecting device it proved more effective than two top language processing programs.
Our results demonstrate that the text embedding, generated by GPT-3, can be reliably used to not only detect individuals with Alzheimers Disease from healthy controls, but also infer the subjects cognitive testing score, both solely based on speech data, study authors wrote.
Todays Diagnostics: Too Little Too Late
Neural messages that volley easily across synapses in a healthy brain are disrupted by these protein accumulations, leading brain cells to cease communication and eventually die. Typical diagnostic methods detect Alzheimers when this process has long been underway because this is when the signs of cognitive impairment become far harder to ignore or attribute to normal aging.
Once Alzheimers disease is suspected in a patient, a physician may recommend a number of diagnostic tests. These may include blood and urine testing, psychiatric and neurological evaluations, or brain imaging through an MRI, CT, or PET scan. An individual may also undergo a lumbar puncture, a procedure that tests the levels of related proteins in the cerebrospinal fluid of the lower back.
These tests are often expensive, and, in the case of the lumbar puncture, invasive and risky. Brain scans may need to be repeated once or twice annually, only to confirm what is already known: that brain cell damage is significant, irreversible, and getting worse. With the global number of people with dementia expected to reach 152 million in less than 30 years, the writing is on the wall: we have to find a way to halt the progression of Alzheimers sooner.
Recommended Reading: Chair Alarms For Dementia Patients
Impact Of A Diagnosis
A major report on the benefits of early diagnosis shows that a diagnosis is often greeted with severe shock, with feelings of disbelief, anger, loss and grief . However, a diagnosis is often regarded by those with dementia and family members as a positive event, particularly when the initial shock has worn off. Critically, the response to a diagnosis depends on how a person with dementia is told about it and the level of support that is available to them and their families after diagnosis.
It is therefore important for the person with dementia and their family to receive the dementia diagnosis in a positive way, with time made available to answer any questions and for support and reassurance to be provided. This is more likely to lead to the individual feeling more in control and empowered to make decisions.
Blood Test Detects Early Onset Of Alzheimers
This year has seen the development of a few types of blood tests that could potentially diagnose Alzheimers before symptoms appear. One test uses fats in the bloodstream to predict the disease within three years with 90% accuracy, while the other blood test examined blood proteins and was able to predict the onset of dementia within a year with 87% accuracy.
The most recent test promises to detect Alzheimers earlier than any other test ever has by looking at a single protein in the brain called IRS-1, which plays a critical role in insulin signaling in the brain and is commonly defective in people with the disease.
Researchers from the National Institute on Aging, who presented the study at the Society for Neuroscience conference in Washington, D.C., gathered blood samples from 174 participants. Of the 174 participants, 70 had Alzheimers, 20 had diabetes and 84 were healthy. They found that the participants who had Alzheimers had higher amounts of the inactive form of IRS-1 and lower amounts of the active form than those adults who were healthy. The participants who were diabetic had intermediate levels of IRS-1.
The results of the study were so consistent across the board that researchers were able to look at results and predict with 100% accuracy if the person was healthy or had Alzheimers.
Also Check: Does Alcohol Help Prevent Alzheimer’s
Future Directions In Diagnosis Research
Considerable research effort is being put into the development of better tools for accurate and early diagnosis. Research continues to provide new insights that in the future may promote early detection and improved diagnosis of dementia, including:
- Better dementia assessment tests that are suitable for people from diverse educational, social, linguistic and cultural backgrounds.
- New computerised cognitive assessment tests which can improve the delivery of the test and simplify responses.
- Improved screening tools to allow dementia to be more effectively identified and diagnosed by GPs.
- The development of blood and spinal fluid tests to measure Alzheimers related protein levels and determine the risk of Alzheimers disease.
- The use of sophisticated brain imaging techniques and newly developed dyes to directly view abnormal Alzheimers protein deposits in the brain, yielding specific tests for Alzheimers disease.
Reviewing Health History And Mental State
If you are experiencing troubling changes in memory, behavior, or thinking abilities, make an appointment to discuss your concerns with a doctor, even if it seems scary.
Primary-care physicians often oversee the diagnostic process but may refer patients to a specialist such as a neurologist, neuropsychologist, geriatrician, or geriatric psychiatrist.
An Alzheimers assessment will include the following:
- Medical and Family History Your history includes past and present illnesses, any medications you take, and any conditions affecting other members of your family.
- Mood Assessment The doctor will look for signs of depression or other mental-health disorders that can cause memory problems or other dementia-like symptoms.
Also Check: How To Take Care Patient With Dementia
Single Brain Scan Can Diagnose Alzheimers Disease
by Maxine Myers20 June 2022
A single MRI scan of the brain could be enough to diagnose Alzheimers disease, according to new research by Imperial College London.
The research uses machine learning technology to look at structural features within the brain, including in regions not previously associated with Alzheimers. The advantage of the technique is its simplicity and the fact that it can identify the disease at an early stage when it can be very difficult to diagnose.
Although there is no cure for Alzheimers disease, getting a diagnosis quickly at an early stage helps patients. It allows them to access help and support, get treatment to manage their symptoms and plan for the future. Being able to accurately identify patients at an early stage of the disease will also help researchers to understand the brain changes that trigger the disease, and support development and trials of new treatments.